Global Protein Therapeutics Market Report 2023: Development of Plasma Derived Therapies Drives Growth

Loading...
Loading...

DUBLIN, May 22, 2023 /PRNewswire/ -- The "Protein Therapeutics Market: Global Market Size, Forecast, Insights, and Competitive Landscape" report has been added to  ResearchAndMarkets.com's offering.


The global protein therapeutics market is expected to grow at a CAGR of around 5.9% during 2023-2030.

Companies Mentioned 

  • Abbott Laboratories
  • Amgen, Inc.
  • AstraZeneca PLC
  • Baxter International, Inc.
  • Biogen, Inc.
  • Boehringer Ingelheim International GmbH
  • Chugai Pharmaceutical Co., Ltd.
  • Diasome Pharmaceuticals, Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Genentech, Inc.
  • Generex Biotechnology Corporation
  • GeneScience Pharmaceuticals Co., Ltd.
  • Hualan Biological Engineering, Inc.
  • Johnson & Johnson
  • Kyowa Hakko Kirin Co., Ltd.
  • Merck Serono SA
  • Novo Nordisk A/S
  • Oramed Pharmaceuticals Inc.
  • Sandoz International GmbH
  • Teva Pharmaceutical Industries Ltd.

This report on global protein therapeutics market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape.

The report presents a clear picture of the global protein therapeutics market by segmenting the market based on product, application, end user, and region.

Also, detailed profiles of companies operating in the protein therapeutics market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Dynamics

Drivers

  • Rise in Prevalence of Chronic Diseases
  • Increasing Geriatric Population
  • Development of Plasma Derived Therapies
  • Increasing Awareness for Protein-Based Therapeutics

Challenges

  • High Development & Manufacturing Cost
  • Stringent Government Regulations
  • Complex Reimbursement Scenario

Historical & Forecast Period

  • Base Year: 2022
  • Historical Period: 2018-2022
  • Forecast Period: 2023-2030

Market Segmentation

 by Product

  • Monoclonal Antibodies
  • Insulin
  • Fusion Protein
  • Erythropoietin
  • Interferon
  • Human Growth Hormone
  • Follicle Stimulating Hormone

by Application

Loading...
Loading...
  • Metabolic Disorders
  • Immunologic Disorders
  • Hematological Disorders
  • Cancer
  • Hormonal Disorders
  • Genetic Disorders
  • Others

by End User

  • Hospitals And Clinics
  • Specialty Centers

by Region

  • Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Rest of Asia Pacific
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America
  • Middle East & Africa
  • Saudi Arabia
  • Turkey
  • Iran
  • Rest of Middle East & Africa

For more information about this report visit https://www.researchandmarkets.com/r/nrezxx

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: Press ReleasesPublishing/Information Services
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...